Standard Biotools Inc.
LAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001162194
No open-market purchases or sales by Standard Biotools Inc. insiders were filed in the last 90 days; 143 institutions reported holding it in 13F filings for Q2 2026, worth $243.6M in total; Viking Global Investors is the only superinvestor holding it.
Superinvestors holding LAB, Q2 2026
1 superinvestor reports holding Standard Biotools Inc. on Form 13F, worth $48.3M in total. Weight is Standard Biotools Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Viking Global InvestorsAndreas Halvorsen | 0.1% | 58,651,170 | $48.3M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of LAB each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2026
1 superinvestor holding at quarter end
- Sold out
- ARK Invest
Q4 2025
2 superinvestors holding at quarter end
- Added
- ARK Invest (+1.5%)
Q3 2025
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−4.2%)
Q2 2025
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−8.6%)
Q1 2025
2 superinvestors holding at quarter end
- Added
- ARK Invest (+3.9%)
Q4 2024
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−62.9%)
Q3 2024
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−29.4%)
Q2 2024
2 superinvestors holding at quarter end
- Reduced
- ARK Invest (−2.8%)
Q1 2024
2 superinvestors holding at quarter end